期刊文献+

冠心病患者服用不同剂量阿司匹林对血小板聚集功能的影响 被引量:4

Different Doses of Aspirin on Platelet Aggregation in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨冠心病患者给予不同剂量的阿司匹林对血小板聚集功能的影响。方法选取2011年6月至2012年8月来我院进行治疗的冠心病患者156例,随机分为2组(n=78),所有的患者均口服阿司匹林,A组服用剂量为100mg,B组服用剂量为200mg,比较PAG在服药前及服药2周后的差异。结果与服用阿司匹林前比较,服药后两组患者的PAG(1)、PAG(5)、PAG(m)值均显著的降低(P<0.05),但是B组降低的幅度更大(P<0.05)。结论冠心病患者每天口服阿司匹林200mg能够更好的抑制血小板的聚集功能,其治疗剂量比较合理。 Objective To explore the different doses of aspirin on platelet aggregation in patients with coronary heart disease.Methods 156 cases with coronary heart disease were selected from June 2011 to August 2012 in our hospital,they were randomly divided into two groups,all the patients were given aspirin,the dose of Group A was 100mg,the dose of group B was 200mg,the difference of PAG between before the medication and medication 2 weeks after were comared.Results Compared with before use aspirin,PAG(1),PAG(5),PAG(m) after medication were significantly lower(P0.05),group B decreased the amplitude greater(P0.05).Conclusions Patients with coronary heart disease daily oral aspirin 200mg better able to inhibit platelet aggregation,its therapeutic dose is more reasonable.
作者 袁玉莲 詹红
出处 《中国医药指南》 2013年第9期29-30,共2页 Guide of China Medicine
关键词 冠心病 血小板聚集 阿司匹林 Coronary heart disease Platelet aggregation Aspirin
  • 相关文献

参考文献6

二级参考文献49

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2郝卫军,司全金,李小鹰.老年心血管疾病患者应用不同剂量阿司匹林抗血小板治疗的临床研究[J].中国临床保健杂志,2006,9(3):210-212. 被引量:4
  • 3孙武,岳永焕,孙彩艳.心内科门诊使用阿司匹林情况的调查[J].中国基层医药,2007,14(6):1022-1023. 被引量:1
  • 4Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients[J].BMJ,2002,324(7329):71-86.
  • 5The SALT Collaborate Group.Swedish Aspirin Low-dose Trial(SALT)of 75mg Aspirin as secondary prophylaxis after cerebrovascular ischemic events[J].Lancet,1991,338(8779):1345 -1491.
  • 6Patrono C,Coller B,FitzGerald GA,et al.Plaelet-active Drugs:The relationships Among Dose,Effectiveness,and Side Effect.The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126suppl3:234-264.
  • 7Krasopoulos G,Brister SJ,Beattie WS,et al.Aspirin "resistance" and risk of cardiovascular morbidity:systematic review and meta-analysis[J].BMJ,2008,336(7637):195-198.
  • 8Michelson AD,Frelinger AL III,Furman MI.Current options in platelet function testing[J].Am J Cardiol,2006,98(10A):4-10.
  • 9Michelson AD.Flow cytometry assessment of glycoprotein movements in Platelets[J].Platelets,1997,8(2):105-115.
  • 10Abrams C,Shattil SJ.Immunological detection of activation platelets in clinical disorder[J].Thromb Haemost,1991,65(5):467-650.

共引文献50

同被引文献37

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部